
Beyond the drug: Closing the knowledge gap for injectable diabetes meds
Despite the decades of R&D and billions spent to bring game-changing drugs like GLP-1s to market, efforts to make sure patients inject the drugs properly have come up short. While prescriptions for updated diabetes medications have skyrocketed, …